In modern bioprocess, efficiency and cost control are critical. Manufacturers constantly look for ways to reduce operational complexity while maintaining sterility, compliance, and reliability. One effective strategy is adopting integrated, ready-to-use assemblies that simplify workflows and reduce hidden operational costs.

Foxx Life Sciences help customers streamline their processes by providing complete sterile assemblies—eliminating the need for customers to build and sterilize systems internally.

The Hidden Costs of In-House Assembly

Many companies still assemble their own fluid management systems by sourcing individual components such as bottles, filters, tubing, connectors, and caps. While this approach may appear flexible, it often introduces several hidden costs:

• Cleanroom requirements – Assembling sterile systems requires controlled environments that are costly to maintain.

• Component sourcing and supply management – Teams must manage multiple vendors and procurement processes.

• Inventory complexity – Each component must be tracked, stocked, and validated.

• Sterilization costs – Facilities must perform sterilization processes or outsource them, adding additional time and expense.

These operational burdens can divert valuable resources away from core research and production activities.

Simplifying the Process with Ready-to-Use Assemblies

Foxx Life Sciences addresses these challenges by offering pre-assembled, sterile fluid management systems such as bottle assemblies, bag assemblies, centrifuge assemblies and flask assemblies. These ready-to-use solutions eliminate the need for customers to assemble and sterilize systems themselves.

Through Foxx’s standard assembly program, customers can receive sterile assemblies within 24–48 hours, significantly reducing downtime and accelerating project timelines.

For more customized applications, Foxx also offers a Made-to-Order (MTO) program, allowing customers to configure assemblies from over 40,000 possible configurations. Customers can instantly generate quotes and receive customized solutions typically within 4–6 weeks. Because Foxx maintains a large inventory of validated raw materials, this approach minimizes supply chain delays while ensuring consistent quality.

Compatibility with Validated Tubing Systems

Foxx also understands that many customers already have validated tubing materials within their processes. To support these requirements, Foxx offers assemblies compatible with multiple tubing options, including:

• EZBio TPE Tubing

• C Flex Tubing

• Advanta Flex Tubing

• Eldon James Tubing

• Freudenberg Tubing

This flexibility allows customers to maintain their validated process materials while still benefiting from Foxx’s pre-assembled sterile solutions.

Local-to-Local Manufacturing Strategy

Another important factor in cost efficiency is supply chain reliability. Foxx operates manufacturing and distribution facilities across North America, Europe, and Asia, enabling a local-to-local strategy.

This global footprint helps customers:

• Reduce shipping times

• Avoid complex import duties and tariffs

• Ensure consistent product availability

• Improve supply chain resilience

For many bioprocess companies operating globally, this localized manufacturing model provides significant logistical advantages.

Enabling More Efficient Bioprocessing

By combining ready-to-use sterile assemblies, flexible configuration options, and global manufacturing capabilities, Foxx helps laboratories and bioprocess manufacturers reduce operational complexity and overall process costs.

Instead of spending time managing components, sterilization, and supply chains, customers can focus on what matters most advancing research, improving production efficiency, and bringing life-saving therapies to market faster.